Amanda Mudek, DPM
Foot & Ankle Surgery · Metairie, LANPI 1134494834
Payments from drug & device makers
What this record shows
This record is dominated by food and beverage: $7,064 of the $8,258 with a category attached, or 85.5%. 27 manufacturers reported payments, led by Stryker at 47.8% of the total.
Across 212 payments — averaging $38.95 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Stryker$4K
- Organogenesis Inc.$1K
- Amgen$501
- Convatec Inc.$477
- Paratek Pharmaceuticals, Inc.$378
- IBSA Pharma Inc.$232
- plus $1K from 21 others
What the payments were for
- Travel & lodging$1,19414%
- Food & beverage$7,06486%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Stryker | 60 | $3,949 |
| Organogenesis Inc. | 24 | $1,314 |
| Amgen(2 entities) | 26 | $501 |
| Convatec Inc. | 12 | $477 |
| Paratek Pharmaceuticals, Inc. | 30 | $378 |
| IBSA Pharma Inc. | 12 | $232 |
| Treace Medical Concepts, Inc. | 3 | $187 |
| Smith+Nephew | 9 | $178 |
| Actelion Pharmaceuticals US, Inc. | 2 | $160 |
| Johnson & Johnson | 2 | $147 |
| Advanced Medical Administration | 1 | $113 |
| Bioventus LLC | 5 | $109 |
| Averitas Pharma Inc. | 3 | $83 |
| GRT US Holding, Inc. | 3 | $63 |
| Nevro Corp. | 3 | $52 |
| AbbVie | 3 | $47 |
| Zimmer Biomet | 2 | $47 |
| Kowa Pharmaceuticals America, Inc. | 3 | $42 |
| Kerecis Limited | 1 | $27 |
| Saluda Medical Americas, Inc. | 1 | $26 |
| Trevena, Inc. | 1 | $23 |
| Polynovo North America LLC | 1 | $21 |
| Biocomposites Inc | 1 | $20 |
| Boston Scientific | 1 | $19 |
| Vertex | 1 | $15 |
| Reprise Biomedical, Inc. | 1 | $15 |
| Nabriva Therapeutics, PLC | 1 | $12 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- AUGMENT INJECTABLE$1,170
- AXSOS$1,020
- VARIAX$1,020
- HOFFMANN$1,020
- GAMMA$1,020
- ORTHOLOC 2 LAPIFUSE$312
- CHARLOTTE$285
- MOTOBAND$245
- KRYSTEXXA$239
- InnovaMatrix AC$182
- ASNIS$169
- N/A$157
- Affinity$150
- TMC NANOPLASTY SYSTEM$144
- PURAPLY WOUND MATRIX$130
- ANCHORAGE$130
- OPSUMIT$125
- AmnioGraft$113
- PuraPly$113
How this compares
$8,258 in reported general payments places this provider in the 75th percentile of 92 foot & ankle surgery providers in Louisiana.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Ammonium Lactate | 38 | $1,031 |
| Ciclopirox | 13 | $318 |
| Celecoxib | 18 | $148 |
| Mupirocin | 18 | $145 |
| Terbinafine Hcl | 14 | $96 |
| Methylprednisolone | 12 | $86 |
| Gabapentin | 12 | $62 |
Paid to pharmacies, not to this prescriber.
Other foot & ankle surgery in Metairie
- Leon WatkinsMetairie$18K
- Beau WillisMetairie$13K
- Nimish ChokshiMetairie$12K
- Alyssa CollinsMetairie$10K
- Chelsea ThayerMetairie$7K
- Jamaya Carter-KirkmanMetairie$2K
- Brian BensonLeesville$278K
- Meredith WarnerBaton Rouge$232K
- Tyson GreenLake Charles$203K
- Bryon McKennaThibodaux$131K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.